Avidian Wealth Solutions, LLC Dexcom Inc Transaction History

Avidian Wealth Solutions, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$110.31 - $140.45 $227,790 - $290,029	2,065 New	2,065 $234,000
Q2 2022 Jul 29, 2022	SELL	$67.99 - $132.89 $57,043 - $111,494	-839 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$94.08 - $130.2 $470 - $651	5 Added 0.6%	839 $429,000
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $108,311 - $135,791	834 New	834 $448,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Avidian Wealth Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Avidian Wealth Solutions, LLC with notifications on news.